Cargando…
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
By targeting the tumor microenvironment to stimulate antitumor immunity, immunotherapies have revolutionized cancer treatment. However, many patients do not respond initially or develop secondary resistance. Based on the limited resources in the tumor microenvironment and competition between tumor a...
Autores principales: | Cerezo, Michaël, Rocchi, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658964/ https://www.ncbi.nlm.nih.gov/pubmed/33177494 http://dx.doi.org/10.1038/s41419-020-03175-5 |
Ejemplares similares
-
Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming
por: Jones, Josh, et al.
Publicado: (2023) -
Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021) -
Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
por: Scholtes, Mathijs P., et al.
Publicado: (2021) -
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
por: Zhao, Lin, et al.
Publicado: (2022) -
Targeting BIP to induce Endoplasmic Reticulum stress and cancer cell death
por: Cerezo, Michaël, et al.
Publicado: (2016)